WILLIAM SAALFELD: Open Payments
NPI 1447772637 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$28,838 in 109 payments from 17 companies in 2025. Trend: 2023 $40,547 · 2024 $36,519 · 2025 $28,838
Speaker / faculty: $16,013Travel & lodging: $6,060Consulting: $4,807Food & beverage: $1,864Education: $93
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 31 | $24,669 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $1,445 |
| SOBI, INC | 5 | $1,361 |
| Amgen Inc. | 31 | $525 |
| ABBVIE INC. | 16 | $247 |
| UCB, Inc. | 11 | $176 |
| Lilly USA, LLC | 1 | $103 |
| GENZYME CORPORATION | 1 | $83 |
| ANI Pharmaceuticals, Inc. | 3 | $63 |
| PFIZER INC. | 2 | $49 |
Products named: TREMFYA, RINVOQ, Bimzelx, PROLIA, EVENITY, TALTZ, OTEZLA, TAVNEOS.
Industry payments across NE — which companies pay providers there.
